Showing results (251-260 of 283) with videos related to
Sort By:
Pageof 29
Oncotarget|September 1, 2018
Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected liversMayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, et al.BMJ Open|November 21, 2022
Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I studyMasahiro Ohira, Tsuyoshi Kobayashi, Yuka Tanaka, et al.Oncotarget|June 5, 2018
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected liversMayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2018
Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinomaTomokazu Kawaoka, Hiroshi Aikata, Tomoki Kobayashi, et al.Journal of Gastroenterology and Hepatology|April 13, 2018
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory statusKenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata, et al.Clinical Journal of Gastroenterology|January 25, 2020
A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunkYumi Kosaka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Journal of Gastroenterology|July 18, 2022
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resectionKenichiro Kodama, Tomokazu Kawaoka, Masanari Kosaka, et al.Oncology|July 10, 2023
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line LenvatinibKikukawa Chihiro, Tomokazu Kawaoka, Shinsuke Uchikawa, et al.Virology|September 22, 2018
Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytesMasataka Tsuge, Nobuhiko Hiraga, Yizhou Zhang, et al.BMC Gastroenterology|December 22, 2022
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varicesYuki Shirane, Eisuke Murakami, Michio Imamura, et al.Pageof 29